A method for preparing polytungstenoxate zeolite materials and their application as acoustic sensitizers in sonodynamic tumor therapy.

By preparing polytungstenoxate zeolite materials through a one-step self-assembly method, the problems of low reactive oxygen yield and insufficient tumor targeting of sonodynamic agents in sonodynamic therapy were solved, achieving a highly efficient effect of killing melanoma cells.

CN123106745APending Publication Date: 2026-11-17HENAN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611303402.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-26
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In current sonodynamic therapy, the reactive oxygen species yield of sonosensitive agents is low, their tumor-targeting accumulation capacity is insufficient, and their biocompatibility needs to be improved. The relationship between the synthesis of polyoxometalate zeolite materials and their sonosensitive properties has not been systematically elucidated.

Method used

Polytungsten oxometalate zeolite materials were synthesized using a one-step self-assembly method. By controlling the molar ratio of the reaction raw materials and the pH value, polytungsten oxometalate zeolite materials with stable three-dimensional zeolite-like framework structure and acid-responsive aggregation properties were prepared and used as sonosensitive agents for sonodynamic tumor treatment.

Benefits of technology

It achieves efficient generation of reactive oxygen species under ultrasound, inducing oxidative stress, mitochondrial dysfunction and inhibition of cellular glycolysis, significantly killing melanoma cells, and possesses good biocompatibility and tumor targeting ability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

This invention relates to a polytungsten oxoate zeolite material with the chemical formula [H2N(CH3)2]. 39 H 11 [[Sn(CH3)2] 3 {[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 The material is prepared by a one-step self-assembly reaction in aqueous solution using sodium tungstate, dimethyltin chloride, cerium nitrate, and dimethylamine hydrochloride as raw materials. The preparation process is simple, the raw material cost is low, and the product yield is high. This material possesses a stable three-dimensional zeolite-like framework structure and acid-responsive aggregation characteristics, while also exhibiting enzyme-like catalytic activity and a matching band structure. Under ultrasound, it can effectively induce a cascade synergistic reaction of oxidative stress, mitochondrial dysfunction, inhibition of cellular glycolysis, and ultrasonic cavitation effect, achieving highly efficient killing of melanoma cells. This material possesses an atomically precise crystal structure, integrating tumor targeting, cascade catalysis, and sonodynamic therapy functions into a single system, providing a novel and reliable technical pathway for the development of precision tumor treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of polyoxometalate materials technology, specifically relating to a method for preparing polytungstenoxate zeolite materials and their application as a sonosensitive agent in sonodynamic tumor treatment. Background Technology

[0002] Sonodynamic therapy is a highly promising non-invasive tumor treatment that utilizes ultrasound to activate a sonosensitive agent, generating toxic reactive oxygen species that precisely kill tumor cells. Its therapeutic precision depends on the targeted accumulation and effective activation of the sonosensitive agent, which is also key to determining the therapy's targeting and in vivo safety (see reference D. Li, YJ Zhu, WW Yin, et al.). Chem. Soc. Rev. 2025 , 54, (7610–7653). While significant progress has been made in sonodynamic therapy research due to its advantages of being non-invasive, having deep tissue penetration, and low toxicity, its clinical translation remains limited by bottlenecks in sonosensitizers, such as low reactive oxygen species yield, insufficient tumor-targeting accumulation capacity, and the need to improve biosafety (see LH Cai, T. Sun, FP Han, et al.). J. Am. Chem. Soc. 2024, 146 (34188–34198). Therefore, developing novel sonosensitizers that combine good biocompatibility, synergistic therapeutic activity, and precise targeting capabilities has become a core research direction for promoting the clinical application of sonodynamic therapy.

[0003] Traditional organic small-molecule sound-sensitizing agents suffer from phototoxicity and pharmacokinetic defects. Therefore, research on inorganic nano-sound-sensitizing agents has rapidly advanced. Their superior physicochemical and structural stability makes them promising candidates for innovative alternative materials (see LH Cai, T. Sun, FP Han, et al.). J. Am. Chem. Soc. 2024, 146 (34188–34198). To address the aforementioned challenges, researchers have focused on polyoxometalate materials. As a class of well-defined classical metal-oxygen cluster compounds, polyoxometalates possess unique intelligent properties and show great application potential in the field of sonodynamic therapy (see references YQ Feng, MY Zhao, JX Yang, et al.). Angew. Chem. Int. Ed. 2025, 64(e202505511). Firstly, polyoxometalates possess atomically tunable crystal structures and energy level arrangements, enabling precise molecular design to adapt to specific therapeutic needs and achieve optimal sonosensitization performance. Secondly, their abundant redox active sites and intrinsic enzyme-like catalytic activity can mediate the cascade reaction of reactive oxygen species / oxygen generation and glutathione consumption in the tumor microenvironment. This process can be further enhanced by external field stimulation such as ultrasound and near-infrared light, effectively overcoming the limitations of tumor hypoxia on sonodynamic therapy and achieving multimodal synergistic anti-tumor activity. However, research on polyoxometalate-based nano-sound sensitizers is still in its early stages, and the structure-activity relationship between their structure and sonosensitization performance has not yet been systematically elucidated. Therefore, designing and synthesizing novel polyoxometalate sonosensitizers with well-defined structures and exploring their mechanisms of action in depth are of great significance for revealing structure-activity relationships and filling key research gaps in this field.

[0004] In the field of polyoxometalate chemistry, three-dimensional polyoxometalate frameworks possess porous structures, high specific surface areas, and good thermal stability, exhibiting structural characteristics similar to metal-organic frameworks and zeolite materials (see KH Yue, RHLu, MB Gao, et al.). Science 2025, 388 (430–436). More importantly, encapsulating polyoxometalate guest units within a porous framework allows the inheritance of the inherent acidity, electronic properties, and catalytic performance of polyoxometalates, effectively enhancing the multifunctionality of hybrid materials. Using metal ions as linkers also enables the construction of highly stable polyoxometalate frameworks, achieving precise molecular synthesis control without introducing organic components (see L. Vilà-Nadal, L. Cronin, 430–436). Nat. Rev. Mater. 2017, 2 In 2017, Professor Cronin's team pioneered the concept of "polyoxometalate zeolites" to describe a new type of material with zeolite topological characteristics and polyoxometalates as structural building blocks (see T. Boyd, SG Mitchell, D. Gabb, et al.). J. Am. Chem. Soc 2017, 139 (5930−5938). However, the controllable preparation and large-scale synthesis of polyoxometalate zeolites still have significant limitations. Most polyoxometalates exhibit poor structural stability during synthesis, and the coordination selectivity among multiple components is difficult to predict, hindering their efficient synthesis. Although the number of reported polyoxometalate zeolite materials is currently limited, their frameworks generally exhibit excellent structural stability, as well as outstanding catalytic, photochemical, and electrochemical properties (see CH Zhan, JM Cameron, D. Gabb, et al, 5930−5938). Nat. Commun 2017, 8 (14185). To this end, researchers are still actively developing novel polyoxometalate zeolite materials, aiming to construct functional materials that combine catalytic activity with multifunctional therapeutic properties. Inspired by the above research ideas, this project aims to develop multifunctional polyoxometalate zeolite materials with tumor therapeutic functions, providing new candidate systems for advanced tumor treatment. The core challenge of this research lies in the rational screening of optimal polyoxometalate building blocks and metal ion linkers, and the establishment of a high-yield, high-precision assembly preparation strategy.

[0005] Based on the above research background, this invention successfully prepared the first polytungstenoxate zeolite material using sodium tungstate, dimethyltin chloride, cerium nitrate, and dimethylamine hydrochloride as raw materials via a one-step self-assembly method. The smallest asymmetric structural unit of this material, the polyanionic structure, has a hollow octahedral cage structure, with adjacent cages connected by [Sn(CH3)2]. 2+ –{W 12 The double-bridge connection forms a hierarchical nested three-dimensional zeolite topology, exhibiting structural stability and acid-responsive aggregation characteristics. Used as a multifunctional nano-acoustic scavenger for cascade catalytic enhancement of sonodynamic therapy, it efficiently generates reactive oxygen species under ultrasound, while also possessing enzyme-like activity and glutathione scavenging capabilities, alleviating tumor microenvironment hypoxia and enhancing oxidative stress-induced tumor apoptosis. This material exhibits excellent biocompatibility and enables highly efficient ablation of melanoma. This is the first example of a polytungstenoxoate zeolite-based acoustic scavenger, providing a reliable strategy for the design of advanced nano-acoustic scavengers in precision tumor treatment and broadening the application fields of polyoxometalate zeolite materials. Summary of the Invention

[0006] The purpose of this invention is to overcome the deficiencies of existing technologies and provide a method for preparing polytungstenoxate zeolite materials, and to explore their application as sonodynamic tumor sensitizers. This material possesses a stable three-dimensional zeolite-like framework structure and acid-responsive aggregation characteristics, while also exhibiting enzyme-like catalytic activity and a matching band structure. Under ultrasound, it can effectively induce a cascade of synergistic reactions involving oxidative stress, mitochondrial dysfunction, inhibition of cellular glycolysis, and ultrasonic cavitation, achieving highly efficient killing of melanoma cells.

[0007] To achieve the above-mentioned objectives, the present invention proposes the following technical solution: A polytungsten oxophosphate zeolite material with the chemical formula: [H2N(CH3)2] 39 H 11 [[Sn(CH3)2]3{[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10)3]}4]·120H2O, abbreviated as {Sn3Ce 40 W 132 It belongs to the cubic crystal system. P -43 m Space group, cell parameters are a = 29.4637(5) Å, b = 29.4637(5) Å, c = 29.4637(5) Å, α = 90º, β = 90º γ = 90º, V = 25577.7(8) Å 3 .

[0008] This invention provides a method for preparing the above-mentioned polytungsten oxosite zeolite material. The method employs a one-step self-assembly process, and its specific steps are as follows: Sodium tungstate, dimethyltin chloride, and dimethylamine hydrochloride were dissolved in distilled water under continuous stirring. The pH of the reaction system was then adjusted to 3.7–4.3, and the mixture was stirred for 10–20 min. Cerium nitrate was then added, and the pH of the reaction system was adjusted to 3.7–4.3 again. The mixture was stirred for 20–30 min, and the solution was heated in a water bath at 85–95 °C for 120–150 min. The solution was then removed, cooled, filtered, and slowly evaporated at room temperature to obtain yellow polyhedral crystals, which are the polytungstate zeolite material.

[0009] Specifically, the molar ratio of sodium tungstate, dimethyltin chloride, dimethylamine hydrochloride, cerium nitrate, and distilled water is 13–17: 0.9–1.3: 18–24: 0.6–0.9: 1200–1600.

[0010] This invention also provides the application of the above-mentioned polytungstenoxate zeolite materials in exerting enzyme-like catalytic activity.

[0011] The present invention also provides the application of the above-mentioned polytungstenoxate zeolite material as a sonosensitive agent in sonodynamic tumor treatment, and evaluates its performance.

[0012] This invention successfully prepared a polytungstenoxate zeolite material through a one-step self-assembly method, using dimethylamine hydrochloride as an organic solubilizer, and by rationally controlling the molar ratio of reactants such as sodium tungstate, dimethyltin chloride, dimethylamine hydrochloride, and cerium nitrate, and adjusting the pH value of the reaction system. Compared with the prior art, this invention has the following advantages: (1) The polytungsten oxoate zeolite material prepared in this invention has a cage-within-a-cage structure, with adjacent cages connected by [Sn(CH3)2]. 2+ -{W 12The double-bridge connection forms a hierarchical nested three-dimensional zeolite topology. Its molecular structure can be precisely resolved using X-ray single-crystal diffraction technology.

[0013] (2) The polytungsten oxoate zeolite material prepared by the present invention is obtained by a one-step self-assembly method. The synthesis process is simple and the reaction conditions are mild.

[0014] (3) This invention also provides the application of polytungstenoxate zeolite materials as sonosensitive agents in sonodynamic tumor treatment. These polytungstenoxate zeolite materials possess a stable three-dimensional zeolite-like framework structure and acid-responsive aggregation characteristics, while also exhibiting enzyme-like catalytic activity and a matching band structure. Under ultrasound, they can effectively induce a cascade of synergistic reactions involving oxidative stress, mitochondrial dysfunction, inhibition of cellular glycolysis, and ultrasonic cavitation, achieving highly efficient killing of melanoma cells. Attached Figure Description

[0015] Figure 1 In the middle, (a) [Ce(H2O)W9O 37 )] 17– (a) Schematic diagram of the structure; (b) [Ce7(H2O)] 13 W9O 37 )] + Structural diagram; (c) [Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3] 8– Schematic diagram of the structure; (d) [Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3] 14– Schematic diagram of the structure; (e) [Sn(CH3)2]3[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3] 8– (f) Schematic diagram of the minimum asymmetric unit of the polytungsten oxoate zeolite framework; (g) Schematic diagram of the structure of the polytungsten oxoate zeolite material; Figure 2 A comparison of the single-crystal X-ray diffraction pattern and the powder X-ray diffraction pattern of polytungstic oxophosphate zeolite materials; Figure 3 Thermogravimetric curves of polytungstoise zeolite materials; Figure 4In the image, (a) the particle size variation of polytungsten oxoate zeolite materials under different pH conditions; (b) a schematic diagram of acid-response aggregation of polytungsten oxoate zeolite materials; and (c) the stability of polytungsten oxoate zeolite materials stored in different media for 7 days (saline is physiological saline, PBS is phosphate buffer solution, and FBS is fetal bovine serum). Figure 5 In the image, (a) is the band gap diagram of polytungstenoxate zeolite material; (b) is the valence band X-ray photoelectron spectrum of polytungstenoxate zeolite material; and (c) is a schematic diagram of reactive oxygen generation and glutathione depletion induced by polytungstenoxate zeolite material under ultrasonic (US) irradiation (GSH is glutathione, GSSH is oxidized glutathione). Figure 6 In the image, (a) is the electron paramagnetic resonance spectrum of singlet oxygen; (b) is the electron paramagnetic resonance spectrum of singlet oxygen of hydroxyl radical (1: polytungsten oxoate zeolite material + water, 2: polytungsten oxoate zeolite material + hydrogen peroxide, 3: ultrasound + hydrogen peroxide, 4: polytungsten oxoate zeolite material + ultrasound + water, 5: polytungsten oxoate zeolite material + ultrasound + hydrogen peroxide). Figure 7 Oxygen generation curves for hydrogen peroxide, polytungsten oxoate zeolite material, and polytungsten oxoate zeolite material + hydrogen peroxide; Figure 8 Comparison of cytotoxicity differences between polytunguoxyate zeolite materials, polytunguoxyate zeolite materials with ultrasound, and dacarbazine (DTIC); Figure 9 Reactive oxygen species (ROS) staining in B16-F10 cells in the phosphate buffer solution group, the sonication group alone, the polytungsten oxoate zeolite material group, and the polytungsten oxoate zeolite material + sonication group (DAPI: 4',6-diamidino-2-phenylindole, scale bar: 20 μm). Figure 10 Mitochondrial membrane potential staining in B16-F10 cells in the phosphate buffer solution group, the sonication group alone, the polytungsten oxophosphate zeolite material group, and the polytungsten oxophosphate zeolite material + sonication group (scale bar: 20 μm); Figure 11 In the study, (a) the glutathione content in B16-F10 cells in the phosphate buffer solution group, the ultrasound-only group, the polytungsten zeolite material group, and the polytungsten zeolite material + ultrasound group; (b) the glucose content inside and outside B16-F10 cells in the phosphate buffer solution group, the ultrasound-only group, the polytungsten zeolite material group, and the polytungsten zeolite material + ultrasound group; and (c) the adenosine triphosphate (ATP) content in B16-F10 cells in the phosphate buffer solution group, the ultrasound-only group, the polytungsten zeolite material group, and the polytungsten zeolite material + ultrasound group. Figure 12The survival rate of B16-F10 cells after co-culturing with the reactive oxygen species scavenger N-acetyl-L-cysteine ​​in the polytunguate zeolite material group and the polytunguate zeolite material + ultrasound group; Figure 13 The hemolysis rate and corresponding optical images of polytungstenoxate zeolite materials; Figure 14 A schematic diagram of melanoma inoculation and treatment protocols; Figure 15 In the study, (a) changes in tumor volume in mice in the phosphate buffer solution group, the ultrasound-only group, the polytungsten oxoate zeolite material group, and the polytungsten oxoate zeolite material + ultrasound combined treatment group during the 14-day treatment period; (b) changes in tumor weight in mice in the phosphate buffer solution group, the ultrasound-only group, the polytungsten oxoate zeolite material group, and the polytungsten oxoate zeolite material + ultrasound combined treatment group after 14 days of treatment. Figure 16 To measure the hematoxylin-eosin staining and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling of mouse tumors in the phosphate buffer solution group, the ultrasound-only group, the polytungstic zeolite material group, and the polytungstic zeolite material + ultrasound combined treatment group 14 days after treatment; Figure 17 In the study, (a) changes in body weight of mice in the phosphate buffer solution group, the ultrasound-only group, the polytungsten oxoate zeolite material group, and the polytungsten oxoate zeolite material + ultrasound combined treatment group during the 14-day treatment period; and (b) survival rates of mice in the phosphate buffer solution group, the ultrasound-only group, the polytungsten oxoate zeolite material group, and the polytungsten oxoate zeolite material + ultrasound combined treatment group. Specific implementation methods

[0016] The present invention will be further illustrated by specific implementation examples below, but the scope of protection of the present invention is not limited thereto.

[0017] In the following examples, all chemical raw materials used are conventional commercially available products. Room temperature refers to 25±5℃. Example 1

[0018] A polytungsten oxophosphate zeolite material with the chemical formula: [H2N(CH3)2] 39 H 11 [[Sn(CH3)2]3{[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3]}4]·120H2O. This material is prepared using a one-step self-assembly process, and the specific synthesis method is as follows: Under stirring conditions, sodium tungstate (4.750 g, 14.400 mmol), dimethyltin chloride (0.252 g, 1.147 mmol), and dimethylamine hydrochloride (1.750 g, 21.459 mmol) were dissolved in 25 mL of distilled water. The pH of the reaction system was then adjusted to 4.0, and after stirring for 10 min, cerium nitrate (0.300 g, 0.691 mmol) was added. The pH of the reaction system was then adjusted to 4.0 again, and stirring was continued for 30 min. Finally, the mixture was heated in a 90 ℃ water bath for 120 min, and then removed. The reaction solution was cooled, filtered, and slowly evaporated at room temperature to obtain yellow polyhedral crystals, which are the polytungsten oxoate zeolite material. Example 2

[0019] A polytungsten oxophosphate zeolite material with the chemical formula: [H2N(CH3)2] 39 H 11 [[Sn(CH3)2]3{[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3]}4]·120H2O. This material is prepared using a one-step self-assembly process, and the specific synthesis method is as follows: Under stirring conditions, sodium tungstate (5.000 g, 15.158 mmol), dimethyltin chloride (0.252 g, 1.147 mmol), and dimethylamine hydrochloride (1.750 g, 21.459 mmol) were dissolved in 25 mL of distilled water. The pH of the reaction system was then adjusted to 4.0, and after stirring for 10 min, cerium nitrate (0.300 g, 0.691 mmol) was added. The pH of the reaction system was then adjusted to 4.0 again, and stirring was continued for 30 min. Finally, the mixture was heated in a 90 ℃ water bath for 120 min, and then removed. The reaction solution was cooled, filtered, and slowly evaporated at room temperature to obtain yellow polyhedral crystals, which are the polytungsten oxoate zeolite material. Example 3

[0020] A polytungsten oxophosphate zeolite material with the chemical formula: [H2N(CH3)2] 39 H 11 [[Sn(CH3)2]3{[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3]}4]·120H2O. This material is prepared using a one-step self-assembly process, and the specific synthesis method is as follows: Under stirring conditions, sodium tungstate (4.750 g, 14.400 mmol), dimethyltin chloride (0.252 g, 1.147 mmol), and dimethylamine hydrochloride (1.750 g, 21.459 mmol) were dissolved in 25 mL of distilled water. The pH of the reaction system was then adjusted to 4.2, and after stirring for 10 min, cerium nitrate (0.300 g, 0.691 mmol) was added. The pH of the reaction system was then adjusted to 4.2 again, and stirring was continued for 30 min. Finally, the mixture was heated in a 90 ℃ water bath for 120 min, and then removed. The reaction solution was cooled, filtered, and slowly evaporated at room temperature to obtain yellow polyhedral crystals, which are the polytungstenoxate zeolite material.

[0021] The crystal structure of the polytungoxate zeolite material prepared above was determined and characterized in the present invention, as follows: The molecular formula of this material is [H2N(CH3)2]. 39 H 11 [[Sn(CH3)2]3{[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3]}4]·120H2O, abbreviated as {Sn3Ce 40 W 132 It belongs to the cubic crystal system. P -43 m Space group, cell parameters are a =29.4637(5) Å, b = 29.4637(5) Å, c = 29.4637(5) Å, α = 90º, β = 90º γ = 90º, V =25577.7(8) Å 3 Characterization by elemental analysis and inductively coupled plasma atomic emission spectrometry revealed that the theoretical and actual contents (C, 2.23%; N, 1.23%; H, 1.53%; Ce, 13.27%; W, 56.94%; Sn, 0.92%) of the prepared polytungsten oxoate zeolite material were in high agreement with the actual contents (C, 2.34%; N, 1.27%; H, 1.60%; Ce, 13.04%; W, 56.48%; Sn, 0.83%), indicating that the molecular formula of the polytungsten oxoate zeolite material is correct.

[0022] The anionic framework of this polytungstenoxate zeolite material simultaneously contains 40 Ce atoms. 3+ This is the highest number of rare-earth nuclei found in a polyoxometalate unit to date. To clearly elucidate the crystal structure of this polytungstenoxometalate zeolite material, a quarter segment of the overall structure [Sn(CH3)2]3[(Ce] was selected. 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3] 8– As a basic structural unit, this unit consists of five structural motifs. Within a single basic structural unit, [Ce(H₂O)W₉O] is a novel rare-earth ion template. 37 )] 17– The structure is located in the center ( Figure 1 a). The [Ce(H2O)W9O 37 )] 17– The structure is based on decacoordinate Ce 3+ The ion serves as the core and the starting site for subsequent bottom-up self-assembly processes. Subsequently, in [Ce(H₂O)W₉O] 37 )] 17– In the fragment, each pair of adjacent {WO6} octahedrons at the equator is associated with a six-coordinate Ce1. 3+ Ion coordination, in [Ce(H2O)W9O 37 )] 17– The outer perimeter forms a coplanar {Ce6} hexagon, producing [Ce7(H2O)]. 13 W9O 37 )] + unit( Figure 1 b). Subsequently, three octagonal Ce2 configurations 3+ The template [CeW5O] 18 ] 3– The ({CeW5}) structural unit is further connected to [Ce7(H2O)] via a Ce–O bridge. 13 W9O 37 )] + Connected, forming [Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3] 8– unit( Figure 1 c). Following this, three saturated [W] 12 O 40 ] 8– ({W) 12 The fragment is connected to the hexagon {Ce6}, producing [Ce 10 (H2O) 13W9O 37 (W5O) 18 )3(W3O 10 )3] 14– unit( Figure 1 d). Finally, the three six-coordinate Sn atoms are connected to the three {CeW5} units through their terminal oxygen atoms, forming [Sn(CH3)2]3[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3] 8– Basic structural unit ( Figure 1 e). Based on this, four such structural units share {W} within a single cell. 12 The fragments assembled to form the smallest asymmetric unit of the hollow octahedral polytungstic zeolite framework, with a molecular size of 36.78. 3 Å 3 ( Figure 1 f). Furthermore, the adjacent polytungsten oxolate zeolite framework's minimum asymmetric unit is located via [Sn(CH3)2]. 2+ –{W 12 The two bridging modes are interconnected to construct the final polytungstenoxate zeolite material. Figure 1 g).

[0023] The powder X-ray diffraction pattern of the polytungsten oxoate zeolite material prepared in this invention is in good agreement with the simulated X-ray diffraction pattern of a single crystal. Figure 2 This proves that the obtained product is of pure phase.

[0024] Thermogravimetric analysis was performed on the polytungoxoate zeolite material in this invention, and the results are as follows: Figure 3 As shown, the material exhibits a three-step thermogravimetric analysis (TGA). The first stage of weight loss occurs in the range of 25–200 °C, with a weight loss rate of 5.03% (theoretical value 5.02%), attributed to the removal of 120 lattice water molecules. The second stage of weight loss occurs in the range of 200–500 °C, with a weight loss rate of 8.08% (theoretical value 7.95%), corresponding to the loss of 39 dimethylamine groups, 3 methyl groups contained in dimethyltin chloride, 52 coordinated water molecules, and the dehydration of 11 protons. When the temperature exceeds 500 °C, the polytungoxoate anionic framework begins to collapse, accompanied by the sublimation of WO3. Overall, the TGA test results of this material are in good agreement with the theoretically derived values.

[0025] This invention evaluates the dynamic behavior and structural stability of the synthesized polytungstenoxate zeolite material in aqueous solution. The hydrated particle size of the material, measured by dynamic light scattering in a phosphate buffer solution at pH 7.4, was 168 ± 2.3 nm. Figure 4 a). Notably, even after 7 days of storage, the particle size remained largely stable, indicating that this polytungsten oxoate zeolite material possesses excellent stability under physiological conditions. More importantly, this stable polytungsten oxoate zeolite material undergoes reactive self-aggregation in a weakly acidic environment (pH 5.5), forming larger nanoparticles. At this point, the hydrated particle size increases to approximately 1925 ± 561.3 nm, while still maintaining good storage stability. Figure 4 a). This acid-triggered self-aggregation behavior is significant for tumor retention because the tumor microenvironment is generally weakly acidic. This acid-responsive self-aggregation phenomenon can be attributed to the protonation process of polyoxometalates induced by acid. Protonation promotes hydrogen bond formation, reduces electrostatic repulsion, and enhances intermolecular attraction, ultimately triggering self-aggregation behavior. Figure 4 b). This unique property facilitates the selective enrichment of the material in tumor tissues, offering significant potential for precise tumor-targeted drug delivery. Furthermore, dynamic light scattering analysis of the material's particle size during 7 days of storage in different media (saline, phosphate-buffered saline, and fetal bovine serum FBS) revealed minimal fluctuations in its hydrated particle size. Figure 4 (c) further confirms that this polytungsten oxoate zeolite material possesses excellent structural and storage stability.

[0026] Subsequently, this invention further investigated the application potential of this polytungstenoxate zeolite material as a sound-sensing agent. The energy level structure of the material was analyzed using ultraviolet-visible-near-infrared spectroscopy and valence band X-ray photoelectron spectroscopy. The calculation results showed that its band gap width was 2.67 eV. This narrow band gap characteristic makes it easier to trigger the separation of electrons (e⁻) and holes (h⁺) through ultrasound, laying the foundation for its sound-sensing performance. Figure 5 a). Combined with valence band X-ray photoelectron spectroscopy (VB-XPS) analysis, the valence band potential of polytungoxoate zeolite materials was determined. E VB-XPS ) is 2.56 eV ( Figure 5 b), then according to the formula E VB vs. NHE = Φ + E VB-XPS – 4.44, which is converted to the valence band energy level relative to the standard hydrogen electrode (NHE). E VB In the formula, the electron work function Φ is taken as 4.2 eV. Calculations show that this material... E VBvs.NHEAt 2.32 eV, this potential is higher than the redox potential of H2O(H2O2) / ∙OH (1.99 eV), allowing for efficient generation of hydroxyl radicals (∙OH). Simultaneously, the remaining holes can consume glutathione (GSH), a major intracellular antioxidant, which weakens the reactive oxygen species-induced tumor treatment effect, thereby further enhancing therapeutic efficacy. Furthermore, due to the conduction band energy level ( E CB vs. NHE (equals the band gap width minus) E VB vs. NHE Thus, the conductive band of the material is derived. E CB vs. NHE The potential is -0.35 eV, which is lower than O2 / ∙O2. – The reduction potential (-0.33 eV) is conducive to the efficient generation of superoxide radicals (∙O2). – These ∙O2 – Free radicals can also combine with holes or ∙OH to generate 1 O2 singlet oxygen ( Figure 5 c).

[0027] To verify the aforementioned reactive oxygen species generation capacity, this invention employs electron spin resonance spectroscopy for experimental verification. The experimental results perfectly match the theoretical predictions. Under ultrasonic (US) irradiation, the aqueous solution treated with this polytungstenoxate zeolite material simultaneously exhibits representative reactive oxygen species in its electron spin resonance spectrum. 1 O2's 1:1:1 triple signal ( Figure 6 a) and the 1:2:2:1 quadruple signal representing ∙OH ( Figure 6 b). The above results fully demonstrate that this polytungstenoxate zeolite material possesses excellent acoustic sensitivity properties, which can meet the application requirements of sonodynamic tumor therapy.

[0028] Furthermore, this invention systematically evaluated the enzyme-like catalytic activity of this polytungstic oxoate zeolite material. The change in dissolved oxygen content within the reaction system was measured using dissolved oxygen assays to assess the material's enzyme-like catalytic activity. Figure 7 It was found that the oxygen content in the hydrogen peroxide solution containing this polytungstic oxoate zeolite material increased significantly with increasing reaction time. In contrast, the oxygen content in the blank control group (without the polytungstic oxoate zeolite material or hydrogen peroxide) remained essentially constant. These results fully demonstrate that the polytungstic oxoate zeolite material possesses excellent enzyme-like catalytic activity, capable of decomposing overexpressed hydrogen peroxide in the tumor microenvironment and generating oxygen. This effect not only effectively alleviates the hypoxic state of the tumor microenvironment but also addresses the key technical problem of decreased efficacy of sonosensitive agents due to hypoxia.

[0029] This invention investigated the inhibitory effect of the prepared polytungstenoxate zeolite material on the proliferation of mouse melanin B16-F10 tumor cells using the CCK-8 assay. The results are as follows: Figure 8 As shown, this polytungstenoxate zeolite material can significantly inhibit the proliferation of B16-F10 tumor cells, with a half-maximal inhibitory concentration (IC50) of [missing value]. 50 The concentration was 1.46 μM. After introducing ultrasound (US) irradiation, the material's killing efficacy against tumor cells increased by nearly two times, IC50 was 1.46 μM. 50 The value further decreased to 0.62 μM. Meanwhile, under the same concentration conditions, the commercial chemotherapy drug dacarbazine (DTIC) showed negligible inhibitory effect on the proliferation of B16-F10 cells. Figure 8 This fully demonstrates the outstanding application potential of the polytungstenoxate zeolite material described in this invention as a novel nano-acoustic agent in the treatment of melanoma.

[0030] Furthermore, based on the excellent reactive oxygen species (ROS) generation capacity of this polytungsten oxoate zeolite material, this invention employs the 2,7-dichlorofluorescein diacetate (DCFH-DA) staining method to detect the ROS generation in B16-F10 tumor cells treated with it. The green fluorescence intensity of this probe is positively correlated with the ROS content in the cells. Figure 9 Staining results showed no significant green fluorescence in either the phosphate buffer solution control group or the ultrasound-only control group. In contrast, tumor cells treated with both polytungstenoxate zeolite material and ultrasound exhibited significant green fluorescence, with a significantly higher fluorescence intensity than the polytungstenoxate zeolite material-only treatment group. These results confirm that the polytungstenoxate zeolite material possesses ultrasound-promoted reactive oxygen species generation capabilities within tumor cells.

[0031] Subsequently, the present invention uses a mitochondrial membrane potential detection kit (JC-1) to detect the mitochondrial membrane potential in B16-F10 tumor cells. Figure 10 The results showed that cells in the phosphate buffer solution control group and the ultrasound-only control group exhibited strong red fluorescence, indicating that mitochondrial function was normal. However, after treatment with a combination of polytungstic zeolite material and ultrasound, B16-F10 cells showed a significant decrease in red fluorescence and a significant increase in green fluorescence, indicating a decrease in mitochondrial membrane potential. This result confirms that the reactive oxygen species induced by this polytungstic zeolite material can lead to depolarization of the mitochondrial membrane potential in B16-F10 cells, thereby causing mitochondrial dysfunction.

[0032] Furthermore, in both the polytungsten oxoate zeolite material treatment group and the polytungsten oxoate zeolite material + ultrasound combined treatment group, the glutathione levels in tumor cells were significantly lower than those in the control group. Figure 11 a). Thus, it can be seen that the ultrasound-enhanced glutathione depletion effect induced by the polytungsten oxoate zeolite material of the present invention can further aggravate the reactive oxygen species burst and mitochondrial damage in B16-F10 cells, ultimately significantly improving anti-tumor efficacy.

[0033] This invention further evaluated the effects of polytungstic oxometalate zeolite materials on the glucose uptake and consumption capacity of B16-F10 cells. The results are as follows: Figure 11 As shown in b, the extracellular glucose levels in the polytungsten oxoate zeolite material group and the polytungsten oxoate zeolite material + ultrasound combined treatment group were significantly higher than those in the phosphate buffer solution control group and the ultrasound control group alone, indicating that the polytungsten oxoate zeolite material can effectively inhibit glucose uptake by B16-F10 cells. Meanwhile, the intracellular glucose content of tumor cells treated with this material alone was reduced by approximately 53% compared to the control group. With additional ultrasound irradiation, this value could be further reduced to 18%, confirming that the material can effectively reduce glucose accumulation in B16-F10 cells.

[0034] Furthermore, the intracellular adenosine triphosphate (ATP) level in B16-F10 cells decreased significantly after treatment with polytungstic zeolite material, and the decrease was even more pronounced when ultrasound stimulation was applied simultaneously. Figure 11 c). This result confirms that the combined effect of polytungoxoate zeolite materials and ultrasound can significantly inhibit the glycolysis process in tumor cells.

[0035] To verify whether the polytunguate zeolite material has any potential mechanical damaging effect on B16-F10 cells, this invention uses non-toxic N-acetyl-L-cysteine ​​as a reactive oxygen species (ROS) scavenger to eliminate ROS-induced cell death. Experimental results show that after ROS scavenging, the polytunguate zeolite material alone treatment group showed extremely low cytotoxicity to B16-F10 cells, indicating that the cytotoxicity of this material mainly depends on the toxic ROS generated during chemodynamic therapy. Figure 12 However, under ultrasound irradiation conditions, this material can still significantly inhibit tumor cell proliferation (IC50). 50 =3.83 μM), which confirms that the polytungsten oxoate zeolite material can induce cavitation under ultrasonic stimulation and achieve tumor cell killing through a physical mechanism.

[0036] Finally, this invention provides a comprehensive and systematic evaluation of the in vivo sonodynamic therapeutic effects of this polytungstic oxolate zeolite material. Firstly, as... Figure 13 As shown, the hemolysis rate of this material is still less than 5.0% at a high concentration of 20 μM, which confirms that it has excellent blood compatibility as a sound-sensitizing agent and provides a reliable safety guarantee for subsequent in vivo experiments.

[0037] Subsequently, C57BL / 6 tumor-bearing mice inoculated with B16-F10 melanoma cells were randomly divided into four groups (n=6 per group): phosphate-buffered saline (PFS) group, ultrasound-only group, polytungsten oxometalate (PTFE) zeolite group, and PFS + ultrasound combined treatment group. During the 14-day treatment period, tumor volume and body weight changes were monitored and recorded every two days. Figure 14The experimental results showed that tumors in mice treated with phosphate buffer and ultrasound alone exhibited a rapid proliferation trend, while the polytungsten oxoate zeolite material group significantly inhibited tumor growth. Crucially, tumor growth in mice treated with a combination of polytungsten oxoate zeolite material and ultrasound was almost completely suppressed. Figure 15 a). Quantitative comparisons of tumor weight further confirmed that both monotherapy with polytungstic oxometalate zeolite and combined treatment with ultrasound significantly inhibited tumor growth. Figure 15 b).

[0038] Furthermore, hematoxylin-eosin (H&E) staining and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining results indicated that the tumor cells in the polytungstic zeolite material + ultrasound combined treatment group exhibited large-scale apoptosis and severe tissue structure destruction. Figure 16 The above results fully demonstrate that the in vivo sonodynamic therapy induced by this polytungstic oxophosphate zeolite material can exert a significant anti-tumor effect.

[0039] Furthermore, during the 14-day treatment period, the body weight of all experimental mice was continuously monitored. The results showed that the body weight of mice in each group did not fluctuate significantly, fully demonstrating that the polytungstenoxate zeolite material has good biocompatibility. Figure 17 a). More importantly, during the 50-day long-term observation period, the survival rate of mice in the polytungsten oxoate zeolite material + ultrasound combined treatment group reached 100%, significantly higher than that of other groups ( Figure 17 (b) This result fully demonstrates the unique advantages of this material in sonodynamic cancer treatment. The above experimental results further confirm that the polytungstenoxate zeolite material described in this invention possesses excellent biocompatibility and extremely low systemic toxicity, with no significant in vivo toxic side effects, laying a solid experimental foundation for its potential clinical application as a high-performance nano-sound-sensitizing agent.

[0040] In summary, the polytungsten oxoate zeolite material provided by this invention possesses a stable three-dimensional zeolite-like framework structure, excellent acid-responsive aggregation ability, and can achieve targeted enrichment through acid-triggered self-assembly. It also exhibits superior enzyme-like catalytic activity and ultrasonic response performance. Its adapted band structure enables it to effectively induce a cascade of reactions involving oxidative stress, mitochondrial dysfunction, and glycolytic inhibition under ultrasonic irradiation, thereby achieving highly efficient killing of melanoma cells. These properties make it a high-performance nano-sound-sensitizer, providing a novel technical pathway and design strategy for precision tumor therapy, and laying a solid foundation for the expanded application of polytungsten oxoate materials in the field of tumor treatment.

Claims

1. A polytungstenoxate zeolite material, characterized in that, The chemical formula of the polytungsten oxoate zeolite material is: [H2N(CH3)2] 39 H 11 [[Sn(CH3)2]3{[(Ce 10 (H2O) 13 W9O 37 (W5O) 18 )3(W3O 10 )3]}4]·120H2O, belongs to the cubic crystal system, P -43 m Space group, cell parameters are a = 29.4637(5) Å, b = 29.4637(5) Å, c = 29.4637(5) Å, α =90º β = 90º γ = 90º, V = 25577.7(8) Å 3 .

2. The method for preparing the polytungstenoxate zeolite material according to claim 1, characterized in that, Includes the following steps: Sodium tungstate, dimethyltin chloride, and dimethylamine hydrochloride were dissolved in distilled water under continuous stirring. The pH of the reaction system was then adjusted to 3.7–4.

3. After stirring, cerium nitrate was added, and the pH of the reaction system was adjusted to 3.7–4.3 again. The mixture was stirred continuously, and finally heated in a water bath at 85–95 °C for 120–150 min. The solution was then removed, cooled, filtered, and evaporated at room temperature. The resulting crystals are polytungoxoate zeolite materials.

3. The method for preparing the polytungstenoxate zeolite material as described in claim 2, characterized in that, The molar ratio of sodium tungstate, dimethyltin chloride, dimethylamine hydrochloride, cerium nitrate, and distilled water is 13–17 : 0.9–1.3 : 18–24 : 0.6–0.9 : 1200–1600.

4. The application of the polytungstenoxate zeolite material of claim 1 in exerting enzyme-like catalytic activity.

5. The application of the polytungstenoxate zeolite material of claim 1 as a sonosensitive agent in sonodynamic tumor treatment.